Cerebras Systems Inc. NASDAQ: CBRS

What we’re investigating

Henzel Law is investigating potential claims on behalf of shareholders of Cerebras Systems Inc. (NASDAQ: CBRS), which designs wafer-scale processors for artificial intelligence workloads. The investigation concerns the accuracy and completeness of the Company’s registration statement and prospectus for its May 2026 initial public offering, and of its later public statements. No lawsuit has been filed yet in this matter.

The firm is particularly interested in hearing from investors who purchased Cerebras shares in or traceable to the May 2026 initial public offering.

The offering

Cerebras priced its initial public offering on May 13, 2026 at $185.00 per share, selling 30,000,000 Class A shares, and began trading on the Nasdaq Global Select Market on May 14, 2026.

The prospectus described the Company’s technology in terms that included its approach to cooling and durability. Among its stated competitive strengths, the Company said it was “among the first in the AI community to deliver water cooling to the processor,” which it said enabled its systems to “run colder and extend our processors’ lifetime.” Elsewhere the prospectus described what was required to “operate a wafer-scale processor reliably and at scale.”

What happened on June 23 and 24, 2026

Forty-one days after the offering, on June 23, 2026, Cerebras reported first-quarter results after the market closed. The Company guided full-year gross margin for its core business to approximately 38% to 41%, against the roughly 47% it had just reported, and disclosed that it would temporarily rent its own systems back from an existing large customer in order to add capacity — an arrangement that would depress margins.

On June 24, 2026, the share price fell approximately 19.6%, closing at $182.26 — below the $185.00 offering price. The chief executive subsequently told a television interviewer that investors had “misunderstood” the margin guidance.

The October 28, 2026 research report

On October 28, 2026, a short-selling research firm published a report asserting that the Company’s wafer-scale processors degrade in service far faster than represented, that the Company programs wafers to run continuous operations so that they never cool, and that the useful life assigned to data-center equipment in the Company’s own filings was lengthened shortly before the offering without explanation. The share price closed down approximately 5.7% that day.

Those assertions are the authors’ and are contested. On November 5, 2026 the chief executive published a detailed rebuttal citing the wafer supplier’s qualification testing, fleet operating temperatures and decommissioning rates, and denied using the connector material the report identified. Henzel Law is evaluating the competing accounts independently and does not adopt either.

What the investigation is examining

The core question is whether the offering materials described the durability, reliability and expected service life of the Company’s processors accurately, and whether they disclosed the margin pressure that emerged six weeks later.

Claims arising from a registered public offering are brought under the Securities Act of 1933. Unlike a fraud claim, they do not require an investor to prove that anyone intended to deceive — it is enough that a registration statement contained an untrue statement of material fact, or omitted a fact needed to make what was said not misleading. That is a meaningfully lower bar, and it is why purchasers in or traceable to the May 2026 offering are the investors the firm most wants to hear from.

The investigation is also weighing the obstacles. The share price has been affected over this period by the expiration of post-offering lock-up restrictions, by analyst price-target reductions, and by a broad decline across artificial-intelligence hardware stocks — none of which is attributable to any alleged misstatement. Separating those influences is necessary work in any case of this kind.

Who this may affect

Investors who purchased Cerebras Systems Inc. (NASDAQ: CBRS) Class A common stock in or traceable to the May 2026 initial public offering, or who purchased in the open market during the period under review and lost money, may have been affected. That period is the firm’s own estimate for purposes of this investigation; it has not been set or approved by any court. If you have questions about your Cerebras holdings, you are welcome to submit your information below for a free, no-obligation review.